Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the ...
Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025 New clinical data from the MATCH Phase II study shows early ...
Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with ...
Understanding the exposome reveals how environmental factors influence health through epigenetics and oxidative stress, ...
Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA ...
LEO mega-constellations are expected to deploy thousands of satellites to provide broadband services with data rates approaching several Gbps and latencies as ...
The atypical teratoid/rhabdoid tumor market growth is driven by rising molecular diagnosis and increased awareness of this ...
MedPage Today on MSN
RDN's Coverage Decision; Intracoronary Stem Cell Tx; Crab-Walk Technique for M-TEER
Similarly, cardiac contractility modulation is also now covered for heart failure under Coverage with Evidence Development, ...
Nisshinbo Micro Devices, a Tokyo-based semiconductor company, has unveiled a new quad-channel power management integrated circuit (PMIC).
A Collaboration with the Kids Research Institute, Octave Bioscience, and Cytokind Quantifies the Benefits of Phototherapy for Multiple Sclerosis Patients INTERVALE, N.H., Oct. 28, 2025 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback